ES8601149A1 - Procedimiento para preparar un ester de metronidazol. - Google Patents

Procedimiento para preparar un ester de metronidazol.

Info

Publication number
ES8601149A1
ES8601149A1 ES523174A ES523174A ES8601149A1 ES 8601149 A1 ES8601149 A1 ES 8601149A1 ES 523174 A ES523174 A ES 523174A ES 523174 A ES523174 A ES 523174A ES 8601149 A1 ES8601149 A1 ES 8601149A1
Authority
ES
Spain
Prior art keywords
metronidazole
ester
formula
dimethylglycine
prepd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES523174A
Other languages
English (en)
Other versions
ES523174A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xellia Pharmaceuticals ApS
Original Assignee
Dumex AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dumex AS filed Critical Dumex AS
Publication of ES8601149A1 publication Critical patent/ES8601149A1/es
Publication of ES523174A0 publication Critical patent/ES523174A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR UN ESTER DE METRONIDAZOL. COMPRENDE: HACER REACCIONAR METRONIDAZOL DE FORMULA (II) CON UN HALURO DE HALOACETILO DE FORMULA (III) EN DONDE HAL Y HAL SON ATOMOS DE CL Y BR EN UN DISOLVENTE ADECUADO Y EN PRESENCIA DE UN EQUIVALENTE QPROXIMADAMENTE DE UNA BASE PARA FORMAR UN COMPUESTO DE FORMULA (IV); HACER REACCIONAR EL COMPUESTO DE FORMULA (IV) CON UN YODURO DE METAL ALCALINO DISUELTO EDN UN DISOLVENTE ORGANICO PARA FORMAR UN COMPUESTO DE FORMULA (V); Y HACER REACCIONAR UN COMPUESTO DE FORMULA (IV) O UN COMPUESTO DE FORMULA (V) CON DIMETILAMINA PARA OBTENER EL COMPUESTO DE FORMULA (I) O UNA SAL DE ADICION DE ACIDO DEL MISMO. SE UTILIZAN EN PREPARADOS PARENTERALES.
ES523174A 1982-06-11 1983-06-10 Procedimiento para preparar un ester de metronidazol. Granted ES523174A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK264382A DK147640C (da) 1982-06-11 1982-06-11 Fremgangsmaade til fremstilling af nitroimidazol-derivater

Publications (2)

Publication Number Publication Date
ES8601149A1 true ES8601149A1 (es) 1985-11-01
ES523174A0 ES523174A0 (es) 1985-11-01

Family

ID=8114115

Family Applications (1)

Application Number Title Priority Date Filing Date
ES523174A Granted ES523174A0 (es) 1982-06-11 1983-06-10 Procedimiento para preparar un ester de metronidazol.

Country Status (14)

Country Link
US (1) US4482722A (es)
EP (1) EP0096870B1 (es)
JP (1) JPS5925377A (es)
AT (1) ATE22558T1 (es)
AU (1) AU564952B2 (es)
CA (1) CA1188305A (es)
DE (1) DE3366566D1 (es)
DK (1) DK147640C (es)
ES (1) ES523174A0 (es)
FI (1) FI832098L (es)
NO (1) NO157619C (es)
NZ (1) NZ204530A (es)
PT (1) PT76844B (es)
ZA (1) ZA834090B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127274A3 (en) * 1983-03-25 1987-05-20 The Upjohn Company Esters of metronidazole and compositions containing them
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
US6423707B1 (en) 2000-08-28 2002-07-23 California Pacific Medical Center Nitroimidazole ester analogues and therapeutic applications
EP1685114B1 (en) * 2003-10-28 2008-10-15 Ems S.A. Antibacterial and/or antiprotozoal nitroimidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines.
US7244765B2 (en) * 2004-06-25 2007-07-17 Cytokine Pharmasciences, Inc Guanylhydrazone salts, compositions, processes of making and methods of using
EP2136797A4 (en) 2007-04-17 2013-08-21 Codman & Shurtleff INTRANASAL ADMINISTRATION OF CURCUMINE IN A HELIUM GAS BOLUS FOR THE TREATMENT OF MORBUS ALZHEIMER
US8383865B2 (en) * 2007-04-17 2013-02-26 Codman & Shurtleff, Inc. Curcumin derivatives
US7745670B2 (en) * 2008-06-27 2010-06-29 Codman & Shurtleff, Inc. Curcumin-Resveratrol hybrid molecule
US7985776B2 (en) * 2008-06-27 2011-07-26 Codman & Shurtleff, Inc. Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease
US20100286585A1 (en) * 2009-01-26 2010-11-11 Codman & Shurtleff, Inc. Shunt Delivery of Curcumin
US7723515B1 (en) * 2009-01-26 2010-05-25 Codman & Shurtleff, Inc. Methylene blue—curcumin analog for the treatment of alzheimer's disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2944061A (en) * 1957-09-20 1960-07-05 Acyl derivatives and process
US3803165A (en) * 1972-08-14 1974-04-09 Hoffmann La Roche N-(2-(2-nitro-1-imidazolyl)ethyl)-2',2',2'-trichloroethyl carbamate

Also Published As

Publication number Publication date
NO157619C (no) 1988-04-20
AU564952B2 (en) 1987-09-03
PT76844B (en) 1986-01-15
NO157619B (no) 1988-01-11
JPS5925377A (ja) 1984-02-09
CA1188305A (en) 1985-06-04
EP0096870A1 (en) 1983-12-28
NO832089L (no) 1983-12-12
DK264382A (da) 1983-12-12
PT76844A (en) 1983-07-01
EP0096870B1 (en) 1986-10-01
FI832098L (fi) 1983-12-12
ATE22558T1 (de) 1986-10-15
DK147640C (da) 1985-05-06
AU1536583A (en) 1983-12-15
FI832098A0 (fi) 1983-06-10
ZA834090B (en) 1984-02-29
ES523174A0 (es) 1985-11-01
NZ204530A (en) 1986-05-09
DE3366566D1 (en) 1986-11-06
US4482722A (en) 1984-11-13
DK147640B (da) 1984-10-29

Similar Documents

Publication Publication Date Title
NO854461L (no) Fremgangsmaate for aa opploeseliggjoere organiske forbindelser.
ES8601149A1 (es) Procedimiento para preparar un ester de metronidazol.
ES8500242A1 (es) Procedimiento para la preparacion de derivados de imidazol
JPS5569586A (en) 11* 66 and 22substitutedd11carbaa22penenn 33carboxylic acid
KR880007507A (ko) 크로만 유도체
KR890008155A (ko) 신규인 유도체, 그 제조방법 및 의약에서의 사용
KR850000451A (ko) 결정성 나트륨 아목시실린의 제조방법
NO901084D0 (no) Natrium-n-acetylneuraminat-trihydrat og fremgangsmaate forfremstilling derav.
KR890008136A (ko) 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체
JPS5762284A (en) Stabilizing method
NO159767C (no) Anvendelse av et hjelpestoff som tilsetning til beta-laktamantibiotikum for aa oeke absorpsjonsgraden av antibiotikumet i blodet ved oral administrering.
SE7907689L (sv) Nya hydroxamsyraforeningar, sett for deras framstellning samt anvendning av dessa foreningar som lekemedel
US4918108A (en) Method of improving the absorption of injected antibacterial substances
NO933016L (no) Fremgangsmaate for sikker administrering av fettsyre
JPS56103185A (en) Malonamidoxa-dethia-cephem compound
SE7903200L (sv) Farmaceutiskt, serskilt diuretiskt verksamt preparat for parenteral administration
KR830006229A (ko) 이미다졸 유도체의 제조방법
FI832209A0 (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara nya indolizinderivat
KR900017591A (ko) 2',3'-디데옥시이노신 모노히드레이트, 2',3'- 디데옥시-2',3'-디데히드로티미딘 모노히드레이트 및 2',3'-디데옥시-2'-플루오로이노신 헤미히드레이트의 수용성이 높고 안정한 항비루스 결정체염
IE35032B1 (en) Phenyl-azolyl-fatty acid derivatives,process for their production and their use as medicines
ATE106878T1 (de) 2-alkyliminobenzothiazoline, ihre herstellung und sie enthaltende arzneimittel.
ATE31191T1 (de) Beta-lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel.
EP0313997A3 (en) Medicine, therein contained phosphor containing 2-isoxazmedicine, therein contained phosphor containing 2-isoxazolidines and isoxazoles, as well as process for preparinolidines and isoxazoles, as well as process for preparing those heterocyclic compounds g those heterocyclic compounds
JPS5531040A (en) Agent to promote absorption of drug through digestive tract
US4742082A (en) Solution of luprostiol and 1,2,-propanediol and methods of preparation and use